Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market, By Type (Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories, Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts), Procedure (Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy, Peripheral Atherectomy), Application (Congenital Heart Defect Correction, Coronary Thrombectomy, Angioplasty, Valvuloplasty, Percutaneous Valve Repair, Others), Age Group (Geriatric, Adults, Pediatric), End User (Hospitals, Ambulatory Surgery Centers, Nursing Facilities, Clinics, Others), Distribution Channel (Direct Tender, Third Party Distributors And Others), Country (South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.
Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Analysis and Size
Interventional cardiology is used in the treatment of structural heart diseases. It is a cardiology subspecialty that diagnoses and treats structural heart disease, coronary artery disease, vascular disease, and congenital heart defects by using specialized catheter-based techniques.
Data Bridge Market Research analyses that the interventional cardiology and peripheral vascular devices market which was USD 15,500 million in 2022, would rocket up to USD 45,000 million by 2030, and is expected to undergo a CAGR of 8.5% during the forecast period. This indicates the market value. Angioplasty Stents dominate the application segment of the interventional cardiology and peripheral vascular devices market owing to the growing demand for surgical procedures. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Type (Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories, Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts), Procedure (Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy, Peripheral Atherectomy), Application (Congenital Heart Defect Correction, Coronary Thrombectomy, Angioplasty, Valvuloplasty, Percutaneous Valve Repair, Others), Age Group (Geriatric, Adults, Pediatric), End User (Hospitals, Ambulatory Surgery Centers, Nursing Facilities, Clinics, Others), Distribution Channel (Direct Tender, Third Party Distributors And Others)
|
|
Countries Covered
|
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Abbott Laboratories (U.S), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S), Becton, Dickinson and Company (U.S), Cardinal Health Inc (U.S), Cook Group (U.S), Medtronic plc (Ireland), Terumo Group (Japan), Koninklijke Philips N.V. (Netherlands), Biotronik SE & Co. KG (Germany), ENDOCOR GmBH (Germany), Andramed GmBH (Germany), and BrosMed Medical (China) among others
|
|
Market Opportunities
|
|
Market Definition
Interventional cardiology is concerned with the use of catheters to treat heart problems. The process entails inserting a device such as a balloon, stent, catheter, or other device into the femoral artery or any other big peripheral artery or vein, and then cannulating the heart under X-ray guidance. Furthermore, a variety of interventional cardiology devices are utilized to treat peripheral vascular problems that impact the circulatory system and can lead to plaque build-up in limb arteries
Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Dynamics
Drivers
- Rising number of the elderly population
The rapidly growing elderly population, increased patient awareness of cardiovascular diseases, and the increasing need to monitor and treat patients are all driving the global interventional cardiology devices market growth. Various governmental and non-governmental organizations, as well as educational institutions and major market players, have launched public awareness campaigns to raise awareness about diseases and treatments, as well as information about the availability of more advanced technologies and procedures at healthcare facilities. Other factors driving market expansion include the development of more advanced and innovative cardiovascular devices, as well as the ease with which regulatory approvals can be obtained. This in turn is expected to carve the way for the growth of the market.
- Increasing number of patients
Growing cases of patients suffering from cardio logical and vascular diseases will boost the growth of the Middle East and Africa interventional cardiology and peripheral vascular devices market. The heart diseases are among the leading causes of death. Thus, the rising cases of heart-associated diseases is expected to upsurge the demand for efficient treatments.
- Growing investment for healthcare facilities
Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. The rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further expected to boost the market.
Opportunities
Furthermore, an upsurge in the public-private funding for target research activities, rising demand for interventional cardiology and peripheral vascular devices, the growing participation of youngsters in sports, and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2030. Additionally, the rising internet penetration rate, increasing adoption of arthroscopic surgeries, rise in the elderly and obese population globally, and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/Challenges
On the other hand, high costs associated with research and development proficiencies, limited infrastructural facilities, high costs associated with heart devices, and a dearth of awareness in backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies, the heavy customs duty imposed on medical devices, and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2030.
This interventional cardiology and peripheral vascular devices market report provide details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the interventional cardiology and peripheral vascular devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In August 2022, Boston Scientific announced the acquisition of Obsidio, Inc. Company to add novel technology Gel Embolic Material technology cleared for use in peripheral vasculature to interventional oncology. The company said it will be helpful for the embolization of blood vessels in the peripheral vasculature.
- In December 2020, Andramed GmBH received the CE mark of AndraStent Aortic for the model XL and XXL and was awarded the seal of approval named Innovative through Research by the Stifterverband für die Deutsche Wissenschaft
Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Scope
The middle east and Africa interventional cardiology and peripheral vascular devices market is segmented on the basis of type, procedure, application, age group, end user and distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Accessories
- Angioplasty Balloons
- Angioplasty Stents
- Angioplasty Catheters
- Endovascular Aneurysm Repair Stent Grafts
Procedure
- Iliac Intervention
- Femoropopliteal Interventions
- Tibial (Below-The-Knee) Interventions
- Peripheral Angioplasty
- Arterial Thrombectomy
- Peripheral Atherectomy
Application
- Congenital heart defect correction
- Coronary thrombectomy
- Angioplasty
- Valvuloplasty
- Percutaneous valve repair
- Others
Age Group
- Geriatric
- Adults
- Pediatric
End User
- Hospitals
- Ambulatory Surgery Centers
- Nursing Facilities
- Clinics
- Others
Distribution Channel
- Direct Tender
- Third Party Distributors
- Others
Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Regional Analysis/Insights
The Middle East and Africa interventional cardiology and peripheral vascular devices market is analysed and market size insights and trends are provided by country, type, price range, application, and end user as referenced above.
The countries covered in the interventional cardiology and peripheral vascular devices market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
Saudi Arabia is expected to dominate the Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market because of the strong base of healthcare facilities, the strong presence of major players in the market increases cases of surgical procedures among athletes, and the rising number of research activities in this region.
Israel is expected to witness significant growth during the forecast period of 2022 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The interventional cardiology and peripheral vascular devices market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the interventional cardiology and peripheral vascular devices market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the interventional cardiology and peripheral vascular devices market. The data is available for the historic period 2010-2020.
Competitive Landscape and Interventional Cardiology and Peripheral Vascular Devices Market Share Analysis
The interventional cardiology and peripheral vascular devices market competitive landscape provide details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the interventional cardiology and peripheral vascular devices market.
Some of the major players operating in the interventional cardiology and peripheral vascular devices market are:
- Abbott Laboratories (U.S)
- B. Braun Melsungen AG (Germany)
- Boston Scientific Corporation (U.S)
- Becton, Dickinson and Company (U.S)
- Cardinal Health Inc (U.S)
- Cook Group (U.S)
- Medtronic plc (Ireland)
- Terumo Group (Japan)
- Koninklijke Philips N.V. (Netherlands)
- Biotronik SE & Co. KG (Germany)
- ENDOCOR GmBH (Germany)
- Andramed GmBH (Germany)
- BrosMed Medical (China)
SKU-